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Background: Themost common symptomof cocaine abuse is chest pain. Cocaine induced chest pain (CICP) shares
patho-physiological pathwayswith the acute coronary syndromes (ACS). A key event is the increase of activity of
the adrenergic system. Beta blockers (BBs), a cornerstone in the treatment of ACS, are felt to be contraindicated in
the patient with CICP due to a potential of an “unopposed alpha adrenergic effect (UAE)”.
Objectives: Identify signs of UAE and in-hospital complications in patients who received BBwhile having cocaine
induced chest pain.
Methods: We performed a retrospective review of 378 patients admitted to a medical unit because of CICP.
Twenty six of these were given a BB at the time of admission while having CICP. We compared these patients
to a control group paired by age, sex, race and history of hypertension who did not received a BB while having
CICP. Blood pressure, heart rate, length of stay and in-hospital cardiovascular complications were compared.
Results: No statistically signiﬁcant differences were found between the two groups except for a longer length of
stay in the case group. This was felt to be due to unrelated causes.
Conclusions: This study does not support the presence of an UAE in patients with continuing CICP and treated
early with BB. There were no in-hospital cardiovascular complications in the group of patients who had an
early dose of BB while having CICP.
Implications: BB appeared safe when given early on admission to patients with CICP.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Cocaine is one of the most common drugs found in patients who
seek EHC. In 2006, six million Americans aged 12 and older had abused
cocaine in some form [1]. Cocaine is a potent vasoconstrictor ([2–4],
Blaho, Merigian et al. 1996, Chang,Walsh et al. 2011). Some of its effects
include hypertension, coronary vasospasm, accelerated atherosclerosis
and myocardial infarction ([5], Chang, Walsh et al. 2011).
The most common symptom of cocaine abuse is chest pain [6]. CICP
shares many of the common patho-physiologic pathways with acute
coronary syndromes ([2,7], Freeman and Feldman 2008). The use of
BB, a cornerstone of the treatment of acute coronary syndromes has
been thought to be contraindicated in patients using cocaine [8]. This
is mainly because of theoretical UAE that can lead to hypertensive com-
plications in patients intoxicated with the drug [6]. There are some




land Ltd. This is an open access articlusing cocaine [9]. Coronary vasoconstriction was induced in one study
when volunteers inhaled cocaine while intra-coronary propranolol
was being infused [10]. Also, there have been reports of increased levels
of cardiac biomarkers in patients who were given beta blockers while
having cocaine induced chest pain [11].
Recent studies have been published showing that BB can be safely
used in patients admitted for cocaine induced chest pain. ([5,12,13],
Ibrahim, Maselli et al. 2013).
Continuing chest pain in patients who test positive for cocaine may
be a marker for the continuing presence of the drug's systemic effects.
We tried to observe the effects of the administration of BB early on
admission which theoretically should have resulted in unopposed
alpha stimulation. As a secondary endpointwe followed troponin levels
during the admission and the patient's length of stay.2. Methods
We performed a retrospective review of all the medical records of
patients admitted to a medical unit for cocaine induced chest pain to
rule out acute coronary syndrome from June 2006 to June of 2009. All
patients had a ﬁnal diagnosis of cocaine induced chest pain and a posi-
tive urine test for cocaine metabolites.e under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Comparison of the basic compared characteristic of the patients groups.
Patient characteristics B-blockers used B-blockers not used P value
(n = 26) (n = 32)
Age (in years) 50 48.3 0.4216
Sex (male) 23 (88.5%) 30 (93.8%) 0.8078
Race 0.6181
Black 14 (53.8%) 15 (46.9%)
Hispanic 10 (38.5%) 16 (50.0%)
White 2 (7.7%) 1 (3.1%)
History of hypertension 18 (69.2%) 18 (56.3%) 0.4163
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the baseline blood pressure (BP) and heart rate (HR) were reviewed.
Values were obtained 1 to 3 h after administration of the beta blocker
and 3 to 6 h later. We also recorded the troponin I values on admission,
6 h after admission and 12 h later. We compared the results to a control
group of patients (paired by age, sex, history of hypertension and race)
also diagnosed with cocaine induced chest pain who did not receive
beta blockers. Statistical comparison of the BP and the HR was done
using the Mann–Whitney test. The troponin values were compared
using the Fisher's exact test. The use of beta blockers was at the discre-
tion of the Emergency Department Physicians.
The data was evaluated using Graph-pad software.3. Results
We found a total 378 patients who were diagnosed with CICP and
admitted to rule out an acute coronary syndrome. From this group we
identiﬁed 26 that while having chest pain received a dose of BB in the
Emergency Department. The type and route of the BB were: oral meto-
prolol 13patients (50%), intravenousmetoprolol 5 patients (19%), intra-
venous labetalol 2 patients (8%), oral carvedilol 2 patients (8%), oral
atenolol 2 patients (8%), and oral propranolol 2 patients (8%).
No statistically signiﬁcant differences were noted in the demo-
graphics of the patients who received and who did not receive beta
blockers. This is outlined in Table 1.
The group with higher BP and HR was more likely to receive BB.
However, there was no statistically signiﬁcant difference between the
two groups. At 6 and 12 h after admission the heart rate and the blood
pressure were lower in the BB group. The results are in Table 2.
Therewas no statistically signiﬁcant difference in the troponin levels
between the two groups studied (Table 3).
The length of stay was signiﬁcantly different (4.6 days in the case
group and 2.65 days in the control group, P: 0.04). However, thisTable 2
Comparison of the blood pressure and heart rate in patients with CICP who received and did n
Time Blood pressure and heart rate in patients that
received beta blockers
Average (95% CI)
0 to 1 h Systolic 147.8 (136.5 to 159.1)
Diastolic 88.5 (80.9 to 96.0)
Mean 108.2 (99.9 to 116.4)
Heart rate 86.4 (80.7 to 92.1)
1–3 h Systolic 135.1 (126.1 to 143.9)
Diastolic 80.01 (72.9 to 87.3)
Mean 98.42 (91.0 to 105.8)
Heart rate 79.63 (75.3 to 83.9)
3 to 6 h Systolic 126.7 (118.3 to 135.2)
Diastolic 75.57 (69.7 to 81.5)
Mean 92.62 (86.4 to 98.9)
Heart rate 73.11 (68.7 to 77.6)might be affected by the presence of patients who stayed in the hospital
because of unrelated issues in both groups.
No cardiac complications were found, and no in-hospital mortality
occurred in either group.
4. Discussion
In our study, the use of BB did not appear to harm patients with con-
tinuing CICP.
We did not observe any documented adverse effects in the cocaine
positive group that received a beta blocker when compared to a similar
group of patients who did not receive the beta blocker. There were no
statistically signiﬁcant differences between systolic, diastolic and
mean arterial BP as well as HR. However, the BP and HR in the beta
blocker group at 6 and 12 h were lower than the ones in the control
group. This ﬁnding is not consistentwith the presence of an “unopposed
alpha effect” in patients using cocaine treated with beta blockers.
There were no differences between the troponin trend in both
groups at any time. The length of stay was increased in the group of
patients that received the BB. This might be secondary to unrelated
co-morbidities and social problems that prevented discharge.
In 2013 in the United States, 24.6 million Americans aged 12 and
older were current illicit drug users. There were 1.5 million cocaine
users aged 12 or older. [14]. Cocaine is the most common drug asso-
ciated to visits to the Emergency Department [15]. The most com-
mon reason for obtaining a consult in the Emergency Department
in cocaine users is chest pain [6].
Cocaine is a potent sympathomimetic. It becomes bioavailable
when absorbed through a mucosal membrane, when inhaled, ingested,
injected or smoked (as in its “crack” form). It acts by blocking the
re-uptake of norepinephrine in the presynapticmembrane. This is asso-
ciated with a signiﬁcant increase of the nor-adrenergic tone leading to
vasoconstriction, hypertension, increased myocardial contractility and
tachycardia. Cocaine is also associated with early atherosclerosis and
thrombus formation including thrombotic myocardial infarctions [16].
Despite the proven beneﬁt of BB in ischemic heart disease this therapy
is contraindicated in patients with chest pain secondary to cocaine [8].
There have been other studies that have found no harm of the use of
BB in patients with cocaine induced chest pain ([17–19], Self, Rogers
et al. 2011, Fanari, Kennedy et al. 2014). In one study the use of beta
blockers was associated with decreased long termmortality in patients
with cocaine induced chest pain [12].
This studywas designed to ﬁnd evidence of the presence of an unop-
posed nor-adrenergic state in patients who had evidence of continuing
cocaine induced chest pain when treated with beta blockers.
It is important to note that all the patients included in our study had
continuing chest pain at the moment the BBs were administered in theot received beta blockers early on admission.




Systolic 135.5 (127.9 to 143.1) 0.0647
Diastolic 82.5 (77.7 to 87.3) 0.1730
Mean 100.17 (94.8 to 105.6) 0.0966
Heart rate 87.6 (81.8 to 93.4) 0.7786
Systolic 133.3 (124.2 to 142.4) 0.8053
Diastolic 77.5 (72.4 to 82.8) 0.5951
Mean 96.1 (89.9 to 102.3) 0.6662
Heart rate 79.1 (74.3 to 83.9) 0.8911
Systolic 130.1 (123.9 to 136.4) 0.5177
Diastolic 76.9 (72.3 to 81.6) 0.7150
Mean 94.7 (90.2 to 99.1) 0.5893
Heart rate 75.8 (71.1 to 80.5) 0.4222
Table 3
Comparison of the troponin trend in between patientswith CICPwho received anddid not
received beta blockers early on admission.
Time Number of patients with
Troponins (+) among those
that received B-blockers
(mean value)
Number of patients with
Troponins (+) among those
that did not receive
B-blockers (mean value)
P value
0–3 h 7/26 (0.1631) 7/32 (0.5406) 0.8900
3–6 h 4/26 (0.0923) 5/32 (0.0372) 0.7612
6–12 h 3/26 (0.0130) 5/32 (0.0597) 1.000
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patients were at increased risk of suffering from acute cocaine toxicity
and therefore at increased risk of having adverse effects from the beta
blocker [20], this was not observed in our study. Interestingly the pa-
tients in our study who received beta blockers were more hypertensive
and tachycardic on admission than the control group however in the
group that received a BB both heart rate and blood pressure were
lower at 6 and 12 h blockers compared to the group that did not receive
a beta blocker.
Our study has several limitations. Because this is a retrospective
review of medical records, the patients did not have a standardized
protocol for follow-up after therapy with beta blockers was started.
Different beta blockerswere used, and administrationwas both intrave-
nous and oral. Also it is important to state that the beta blockers were
given to patients with acute cocaine induced chest pain and were
discontinued after determining the presence of cocaine metabolites in
the urine. The test for the presence of cocaine metabolites in the urine
is a qualitative analysis and we cannot estimate the amount of cocaine
ingested by the patients in either group.
Our study does not support the theory of an UAE in patients who
received BB while having CICP in the Emergency Department. Our con-
clusions are supported by not ﬁnding a statistical difference in troponin
levels or cocaine associated complications either group.
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